MedTrace Logo

Uncontrolled Hypertension Management (TEAM-HTN)

NCT03281772 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 70

Last updated 2025-04-16

No results posted yet for this study

Summary

Current guideline directed medical therapies (GDMT) for hypertension (HTN) endorse a trial and error approach based on drug class. This pilot study will evaluate the efficacy of a Clinical Decision Support (CDS) program to assist providers with delivering a more personalized approach using individual renin-aldosterone levels and the mechanism of action of medications included in GDMT recommendations. The overarching goal is to achieve HTN control rates above the 2014 National Health and Nutrition Examination Survey reported rate of 53% in a timely fashion, by individualizing medication management, thereby reducing the patient risk of stroke, heart and renal disease, and other devastating HTN-related outcomes.

Conditions

Interventions

OTHER

Clinical Decision Software - provider portal

As noted in Arms

OTHER

Clinical Decision Software - patient portal

As noted in Arms

Sponsors & Collaborators

  • Telemedicine & Advanced Technology Research Center

    collaborator OTHER

  • Analytics4Medicine, LLC

    collaborator UNKNOWN

  • Madigan Army Medical Center

    lead FED

Principal Investigators

  • Leilani A. Siaki, PhD · Madigan Army Medical Center

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-01-24
Primary Completion
2018-07-31
Completion
2018-07-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03281772 on ClinicalTrials.gov